Virax Biolabs enters at-the-market offering agreement for ordinary share sales
VRAX•At-the-market offering filing
Virax Biolabs filed a legal opinion supporting the issuance and sale of ordinary shares.
Disclosure referenced an at-the-market offering agreement with a sales agent, dated Jan. 22, 2024.
The filing incorporated the report into its registration statement and related prospectus supplements.
